Pancragen
Also known as: Pancreas Bioregulator, Pancreatic Peptide
A Khavinson bioregulator peptide for pancreatic function and glucose metabolism.
Overview
Pancragen is a synthetic tetrapeptide from the Khavinson bioregulator family designed to support pancreatic function. It may help normalize insulin production and glucose metabolism, particularly during aging or in metabolic disorders.
Mechanism of Action
Gene regulatory effects on pancreatic tissue. Proposed to normalize protein synthesis in beta cells and exocrine pancreas. May support insulin secretion and pancreatic enzyme production.
Pharmacokinetics
Small peptide allows oral/sublingual administration. Tissue-specific effects on pancreas.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Metabolic Support
10-20 mg
1-2x daily
10-30 days
2-3 courses per year
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Improved glucose tolerance in studies
- 2Support for pancreatic beta cell function
- 3Gene expression modulation in pancreatic tissue
- 4Part of metabolic bioregulator protocols
Side Effects & Contraindications
Reported Side Effects
- Generally well-tolerated
- Monitor glucose levels
Contraindications
- Acute pancreatitis
Safety Considerations
Generally well-tolerated. Monitor blood glucose. May complement but not replace diabetes medications.
Storage Requirements
Store at room temperature
Scientific References
- 1